Search results

An approximate guide to the timings for the development of a piece of HealthTech guidance.

Our Medical Technologies Evaluation Programme (MTEP) evaluates new HealthTech.

We want you to be involved in our work - whether you’re commenting on our draft recommendations, taking part in guidance development or attending a committee meeting, your voice is important to us.

NICE has a key role in UK licensing and the evaluation of and access to new and innovative products for the health system.

Home What NICE does Our guidance About technology appraisal guidance {"@context":"http://schema.org","@type":"BreadcrumbList","itemListElement":

Data on the cancer recommendations made by our technology appraisal programme. Includes information on the number of positive recommendations we've made.

All the templates and supporting documents you need to make a technology appraisals submission with NICE.

Clarification on demonstrating patient access to medicines and treatments recommended by NICE Technology Appraisal (TA) or Highly Specialised Technologies (HST) guidance.

Data on the recommendations made by our technology appraisal programme. Includes information on the number of positive recommendations we've made.

NICE makes 4 types of recommendation that allow us to produce clear, directive, actionable guidance that is easy to understand and put into practice.

We work with the Terminology and Classifications delivery service of NHS England to provide relevant clinical coding information for interventional procedures guidance.

Our Medical Technologies Evaluation Programme (MTEP) considers technologies that could offer benefits to patients and the health and social care system over current practice.

People have the right to be able to make informed decisions about their care. Our guidance should be taken into account when making decisions with them.

The guidance development timeline

Resources, case studies and patient decision aids to show how you can use evidence to improve care and services